OC. W/ antimineralocorticoid & antiandrogenic effects, for women who experience hormone-related fluid retention & the resulting symptoms, & for women w/ acne & seborrhea.
Nausea, emotional liability, migraine, decreased & loss of libido; depressed or altered mood; breast pain, unscheduled uterine bleeding, genital tract bleeding (not further specified).
Drug Interactions
Phenytoin, barbiturates, primidone, carbamazepine, rifampicin, oxcarbazepine, topiramate, felbamate, ritonavir, griseofulvin, products containing St. John's wort, cyclosporin, lamotrigine, melatonin, drugs that increase serum K levels (angiotensin-II-receptor antagonists, K-sparing diuretics & aldosterone antagonists). HIV/HCV protease inhibitors non-NRTIs can increase or decrease plasma conc of estrogen or progestin. Drospirenone causes an increase in plasma renin activity & plasma aldosterone induced by its mild antimineralocorticoid activity.
G03AA12 - drospirenone and ethinylestradiol ; Belongs to the class of progestogens and estrogens in fixed combinations. Used as systemic contraceptives.
Sign Out
